key: cord-1026647-mudmkn5h
authors: Iliyasu, Zubairu; Perkins, Jessica M.; Tsiga-Ahmed, Fatima I.; Galadanci, Hadiza S.; Jibo, Abubakar M.; Amole, Taiwo G.; Umar, Amina A.; Abdullahi, Hadiza M.; Kwaku, Aminatu A.; Salihu, Hamisu M.; Aliyu, Muktar H.
title: COVID-19 Vaccine Acceptability Among Pregnant Women in Northern Nigeria
date: 2022-03-16
journal: J Obstet Gynaecol Can
DOI: 10.1016/j.jogc.2022.01.002
sha: 781d2bed7a11b1b0df76a86f730e7f4e8ebc4fbc
doc_id: 1026647
cord_uid: mudmkn5h

nan

I ncreasing vaccine uptake among pregnant women is a critical part of combating the coronavirus disease 2019 (COVID-19) pandemic. 1 The prevalence and correlates of vaccine acceptance among pregnant women in Nigeria are unknown. We assessed acceptability and correlates of COVID-19 vaccines among pregnant women attending an antenatal clinic in Nigeria.

The study was conducted at Aminu Kano Teaching Hospital in Nigeria, a 750-bed referral facility serving w13 million people. Systematic sampling was used to recruit consenting pregnant women upon arrival for antenatal care (n ¼ 420). Quantitative data were collected using an adapted, interviewer-administered, structured questionnaire. 2,3 A variable representing vaccine acceptability was created based on a five-point Likert scale (very keen ¼ 1 to against it ¼ 5). Vaccine acceptability was defined as "yes" if a respondent answered "very keen" or "pretty positive" and "no" for any other response. Multivariable logistic regression was employed to assess factors independently associated with vaccine acceptability. Adjusted odds ratios and 95% confidence intervals were computed. Hosmer-Lemeshow statistic and omnibus tests were used to determine model fitness. The respondent's religion, number of living children, education, income, gestational age at booking, self-assessed health status, risk perception, and vaccine safety concerns were independently associated with COVID-19 vaccine acceptability (Table, online Appendix) . For example, non-Muslim respondents had a four-fold increased likelihood of accepting the vaccine during pregnancy. Similarly, respondents with primary education were six times more likely to accept the vaccine. Furthermore, primigravid women and those who booked early (12 weeks gestational age) for antenatal care had three-fold increased odds of accepting COVID-19 vaccination during pregnancy. Women who received tetanus toxoid in the current pregnancy and those who selfassessed their health status as "good" or "very good" had at least a four-fold increased likelihood of accepting the COVID-19 vaccine. Finally, pregnant women who were not concerned about COVID-19 vaccine safety were eight times more likely to accept the vaccine.

In conclusion, we found low COVID-19 vaccine acceptance among pregnant women seeking antenatal care in Nigeria. Vaccine acceptability was associated with several sociodemographic and health-related factors. Our findings present an opportunity for public health action to reduce misconceptions about the COVID-19 vaccine. Our results will inform the design of interventions to build trust and boost COVID-19 vaccine confidence among pregnant women in similar settings. 

COVID-19 vaccination in pregnancy and lactation: current research and gaps in understanding

COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II

COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics

The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada